Rare disease

2 stories tagged Rare disease on Learning Fanatic.

Update: FDA approves Inovio's Voceryq for a rare airway disease The FDA granted accelerated approval to Inovio's DNA immunotherapy Voceryq on 30 October 2026; 7 of 26 patients needed no surgery in a year.
Upcoming: FDA decision due today on Inovio's INO-3107 The FDA's target date to decide on Inovio's DNA therapy INO-3107 for a rare airway disease is 30 October 2026. No outcome has been reported yet.